Clik here to view.
Continuing Medical Education Controversy
Big-Pharma Reacts to Criticism Staff Reporters Pfizer Inc., hoping to temper criticism that it is improperly influencing doctors, is eliminating direct financial support for continuing medical...
View ArticleClik here to view.
Prescription Quantity Survey
The IMS Health Data Study Staff Reporters Did you know that the number of prescriptions dispensed by pharmacies in the U.S. is growing at its worst rate in at least a decade, as consumers are squeezed...
View ArticleClik here to view.
Disclosures Lacking in Drug Studies
New – Dark Alley – Report on Drug Studies Staff Reporters A report in Bloomberg News, January 13, says that drug regulators haven’t done enough to force disclosure of financial conflicts among the...
View ArticleClik here to view.
On Drug Reps as Future Dinosaurs
More Doctors Closing Office Doors to Drug Salesmen By Staff Reporters According to Kevin B. O’Reilly, of the AMNews on 3/23/09, drug reps may soon become dinosaurs-of-sorts. And, the relationship...
View ArticleClik here to view.
More JAMA [Hypocritical] Censorship on Big-Pharma Funding
Janus-Like Opposing Views Becoming Contentious Staff Reporters According to Tracy Staton, the Journal of the American Medical Association may be fighting to keep long-running internal arguments over...
View ArticleClik here to view.
Enter Margaret Hamburg
The New FDA Nominee By Staff Reporters According to Tracy Staton and FiercePharma on April 7, Dr. Marcia Angell, former New England Journal of Medicine editor-in-chief and current Harvard Medical...
View ArticleClik here to view.
Beware the Faux Medical Journals
When is a “Journal” … not a Journal? By Dr. David Edward Marcinko; MBA, CMP™ Publisher-in-Chief Allow me to begin this post by making the unusual disclosure that I am the Editor-in-Chief of a print...
View ArticleClik here to view.
How a Few Private Health Insurers Are on the Way to Controlling Health Care
A Re-Post from Robert Reich; PhD Staff Reporters The healthcare public option is dead, killed by a handful of senators from small states who are mostly bought off by Big Insurance and Big Pharma -or-...
View ArticleClik here to view.
What We’re Up to at the ME-P and Why?
A Letter from the Editors By Dr. David Edward Marcinko; MBA, CMP™ By Hope Rachel Hetico; RN, MHA, CMP™ As many of you know, we founded the Medical Executive Post [ME-P] as a not-for-profit in 2006, and...
View ArticleClik here to view.
Docs on Pharma Payroll Have Blemished Records
Limited Credentials By Charles Ornstein , Tracy Weber and Dan Nguyen ProPublica, Oct. 18, 2010, 11:52 p.m. The Ohio medical board concluded [1] that pain physician William D. Leak had performed...
View ArticleClik here to view.
Pfizer’s Latest Twist on ‘Pay for Delay’
Protecting Brand-Named Drugs By Marian Wang ProPublica, November, 14th, 2011, 2:41 pm Pharmaceutical companies have sought for years to protect their expensive brand-name drugs by paying generic rivals...
View Article
